Home

Loading...

Table of contents

Chordoma

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of chordoma are prepared by our editorial team based on guidelines from the European Reference Network on Genetic Tumour Risk Syndromes (GENTURIS/ERN PaedCan/EURACAN/ESMO 2021) and the National Comprehensive Cancer Network (NCCN 2021). ...
Show more

Diagnostic investigations

History and physical examination: as per ERN PaedCan/ESMO/EURACAN/GENTURIS 2021 guidelines, elicit medical history and perform physical examination in the initial work-up of patients with suspected primary bone sarcoma.
B
Create free account

More topics in this section

  • Imaging for staging

Diagnostic procedures

Biopsy and histopathology: as per ERN PaedCan/ESMO/EURACAN/GENTURIS 2021 guidelines, perform biopsy in the initial work-op of patients with suspected primary bone sarcoma.
B
Show 4 more

Medical management

Setting of care: as per ERN PaedCan/ESMO/EURACAN/GENTURIS 2021 guidelines, manage patients with bone sarcomas at reference centers and/or within reference networks able to provide access to the full spectrum of care and age-specific expertise.
B

More topics in this section

  • Chemotherapy

  • Management of metastatic disease

Therapeutic procedures

Radiotherapy: as per ERN PaedCan/ESMO/EURACAN/GENTURIS 2021 guidelines, offer definitive radiotherapy (without debulking) in the following cases:
inoperable patients
R0 or R1 resection cannot be achieved according to an expert center
neurological impairment not accepted by the patient.
B
Show 2 more

Surgical interventions

Surgical excision: as per ERN PaedCan/ESMO/EURACAN/GENTURIS 2021 guidelines, consider performing surgery in patients with a chordoma arising from S4 and below or in the context of other alternatives for tumors originating above S3.
C
Show 3 more

Follow-up and surveillance

Surveillance: as per ERN PaedCan/ESMO/EURACAN/GENTURIS 2021 guidelines, consider obtaining follow-up approximately every 3 months for the first 2 years, every 6 months for years 3-5, every 6-12 months for years 5-10, and every 0.5-1-2 years thereafter.
C
Show 2 more

More topics in this section

  • Management of recurrent disease